Medical tests

How to Navigate Food Allergies, According to Registered Dietitian Katie Ferraro

Retrieved on: 
Thursday, May 3, 2018
Medicine, Immunology, Clinical medicine, RTT, Allergology, Medical tests, Food allergies, Immune system, Allergy test, SunButter, Food Allergy Research & Education, Allergy

To commemorate National Food Allergy Awareness Week (May 13 19), SunButter , the maker of premium allergy-friendly sunflower butters, joins forces with registered dietitian Katie Ferraro to identify five essential tips for navigating food allergies:

Key Points: 
  • To commemorate National Food Allergy Awareness Week (May 13 19), SunButter , the maker of premium allergy-friendly sunflower butters, joins forces with registered dietitian Katie Ferraro to identify five essential tips for navigating food allergies:
    Get a medical diagnosisAvoid self-diagnosing food allergies as it may lead to unnecessary restrictions.
  • Consult with a registered dietitianOnce you have a food allergy diagnosis, a dietitian can help craft a well-balanced meal plan consisting of foods you and your family can eat.
  • Find a food allergy support group or online community, like the Food Equality Initiative , Kids With Food Allergies , Food Allergy Research & Education and Food Allergy & Anaphylaxis Connection Team , to share ideas and experiences with.
  • "My most valuable recommendation for families with food allergies is to approach the diagnosis of a new food allergy as an opportunity to try new foods," says Katie Ferraro, MPH, RDN, CDE.

Glucose Biosensor Market Size to Reach $31 Billion by 2022 | Million Insights

Retrieved on: 
Thursday, May 3, 2018
Biosensors, Biotechnology, Endocrine system, Medicine, Clinical medicine, Medical tests, Diabetes, Fluorescent glucose biosensor, Sensor, Insulin

The global Glucose Biosensor Market was estimated at USD 15.3 billion in 2015 and is anticipated to reach USD 31.0 billion by 2022.

Key Points: 
  • The global Glucose Biosensor Market was estimated at USD 15.3 billion in 2015 and is anticipated to reach USD 31.0 billion by 2022.
  • In totaling, growing requirement for point of care diagnostics and home care diagnostics, and increase in utilization of glucose biosensor in nonmedical functionality will further encourage the industry of glucose biosensor.
  • Browse 58 page research report with TOC on "Global Glucose Biosensor Market" at: https://www.millioninsights.com/industry-reports/glucose-biosensor-market
    On the basis of types, there are typically two types of glucose biosensors purposely amperometric biosensors and fluorescence glucose.
  • Moreover, by the improvement in fluorescent glucose biosensor, it is likely to capture the huge market share over the forecast period.

IVD Contract Manufacturing Market, 2022

Retrieved on: 
Wednesday, May 2, 2018
Medical tests, Biology, IVD, Immunoassay, Molecular diagnostics

The "Contract Manufacturing in IVD: Market Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Contract Manufacturing in IVD: Market Analysis" report has been added to ResearchAndMarkets.com's offering.
  • This report, Contract Manufacturing in IVD: Market Analysis, looks at this industry.
  • The report provides market projections and examines the companies that build IVD devices, reagents, antibodies, and other accessories for major IVD companies.
  • For each major market segment, the report breaks out the contracting market for IVD products, including market sizing and regional trends for 2017 with forecasts to 2022 for the following:
    Global Contract IVD Manufacturing Demand by Technology, 2017-2022 (Global IVD Demand, % contract manufacturing, Global Contract IVD Mfg Demand, POC, Immunoassay, Clinical Chem, Microbiology, Molecular, Hematology, Histology/Cytology, Coagulation, Blood Grouping)
    Global Contract IVD Manufacturing Demand by Country/Region, 2017-2022 (World; N America: US, Canada, Mexico; W Europe: France, Germany, Italy, Spain, UK, Other; Asia/Pacific: Australia, China, India, Japan, S. Korea, Other; C & S America; E Europe; Afr/Mideast)
    Global Contract IVD Manufacturing Demand by Product Group, 2017-2022 (Global Contract IVD Mfg Demand, Reagents & Consumables, Instruments & Systems, Supplies & Accessories)
    Global Contract Point of Care (POC) IVD Product Demand by Type, 2017-2022 (Total POC IVD Product Revenues; % contract; Contract POC IVD Product Revenues; Reagents & Consumables: Glucose, Antibodies, Other Reagents, Standards & Controls; Instruments & Systems: Full, Components; Accessories)
    Global Contract Immunoassay Product Demand by Type (Total Immunoassay Product Revenues; % contract; Contract Immunoassay Product Revenues; Reagents & Consumables: Antibodies, Enzymes, Other; Instruments & Systems: Full, Components; Accessories)
    Global Contract Clinical Chemistry Product Demand by Type (Total Clinical Chemistry Product Revenues; % contract; Contract Clinical Chemistry Product Revenues; Reagents & Consumables: Glucose, Lipids, Enzymes, Electrolytes, Proteins, Toxicology, Other Reagents, Standards & Controls; Instruments & Systems: Full, Components; Accessories)
    Global Contract Microbiology IVD Product Demand by Type (Total Microbiology IVD Product Revenues; % contract; Contract Microbiology IVD Product Revenues; Reagents & Consumables: ID/STAT, Media, Other; Instruments & Systems: Full, Components; Accessories)
    Global Contract Molecular Diagnostics Demand by Type (Total Molecular Diagnostic Product Revenues; % contract; Contract Molecular Diagnostic Product Revenues; Reagents & Consumables: Amplified Probes, Direct Probes, Other; Instruments & Systems: Full, Components, Accessories)
    Global Contract Hematology IVD Product Demand by Type, 2017-2022 (Total Hematology IVD Product Revenues; % contract; Contract Hematology IVD Product Revenues; Reagents & Consumables: Enzymes, Other; Instruments & Systems: Full, Components; Accessories)
    Global Histology/Cytology IVD Product Demand by Type (Total Histology/ Cytology IVD Product Revenues; % contract; Contract Histology/ Cytology IVD Product Revenues; Reagents & Consumables: DNA Probes, Antibodies, Other; Instruments & Systems: Full, Components; Accessories)
    Global Contract Coagulation IVD Product Demand by Type (Total Coagulation IVD Product Revenues; % contract; Contract Coagulation IVD Product Revenues; Reagents & Consumables; Instruments & Systems: Full, Components; Accessories)
    Global Contract Blood Grouping IVD Product Demand by Type (Total Blood Grouping IVD Product Revenues; % contract; Contract Blood Grouping IVD Product Revenues; Reagents & Consumables; Instruments & Systems: Full, Components; Accessories)

Global $928 Million Consumer DNA (Genetic) Testing Market 2018-2023 with 23andMe, Ancestry, Color Genomics and Gene by Gene Dominating

Retrieved on: 
Wednesday, May 2, 2018
Genetics, Applied genetics, Biology, Bioinformatics, Biological databases, 23andMe, Medical tests, Color Genomics, Genomics, Draft:Xcode Life, DNA encryption

The "Global Consumer DNA (Genetic) Testing Market - Forecasts from 2018-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Consumer DNA (Genetic) Testing Market - Forecasts from 2018-2023" report has been added to ResearchAndMarkets.com's offering.
  • The global consumer DNA (genetic) testing market was valued at US$359.05 million in 2017 and is projected to expand at a CAGR of 15% over the forecast period to reach US$928.80 million by 2023.
  • The recent regulatory approval for conducting various tests has been instrumental in the rapid growth of the market.
  • Major industry players profiled as part of the report are 23andMe Inc., Ancestry, Color Genomics Inc., and Gene by Gene Ltd. among others.

Global In-Vitro Diagnostics/IVD Market 2018-2023: Increasing Adoption of Fully Automated Instruments and Automation in Laboratories

Retrieved on: 
Wednesday, April 25, 2018
Medicine, Biotechnology, Clinical medicine, Biology, Medical tests, Molecular diagnostics, Hematology, Personalized medicine

The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%.

Key Points: 
  • The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%.
  • The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.
  • On the basis of technology, the market is broadly divided into immunochemistry/immunoassay, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies.
  • On the basis of end user, the market is segmented into laboratories, hospitals, academic institutes, point-of-care testing, patient self-testing, and other end users.

Global Infectious Disease Diagnostics Market 2018-2022: Shift in Focus From Centralized Laboratories to Decentralized Point-Of-Care Testing

Retrieved on: 
Wednesday, April 25, 2018
Technology, Bio-Rad Laboratories, Biochemistry, Becton Dickinson, Infection, Health, Biology, Medical tests

The "Infectious Disease Diagnostics Market by Product & Service, Disease Type, Technology, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Infectious Disease Diagnostics Market by Product & Service, Disease Type, Technology, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
  • The global infectious disease diagnostics market is projected to reach USD 19.35 Billion in 2022 from USD 14.73 Billion in 2017, at CAGR of 5.6%.
  • Growth in this market is largely be driven by the increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.
  • The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomrieux (France), Bio-Rad (US), and Roche (Switzerland)

Biocompare Launches Trends in Flow Cytometry Future Lab

Retrieved on: 
Wednesday, April 25, 2018
Biology, Medicine, Blood tests, Cell biology, Clinical pathology, Laboratory techniques, Medical tests, Clinical medicine, Flow cytometry, Cytometry, Flow cytometry bioinformatics

SOUTH SAN FRANCISCO, Calif., April 24, 2018 /PRNewswire/ --Biocompare, the leading online information resource for the life sciences, has re-launched its digital flow cytometry information hub Future Lab: Trends in Flow Cytometry .

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 24, 2018 /PRNewswire/ --Biocompare, the leading online information resource for the life sciences, has re-launched its digital flow cytometry information hub Future Lab: Trends in Flow Cytometry .
  • The interactive Future Lab is designed as a comprehensive information resource for the latest technological advances in flow cytometry.
  • Since their launch in 2016, the Future Lab content hubs have developed a global audience of over 2.4 m scientists.
  • The new Flow Cytometry Future Lab has been completely redesigned to deliver information in an easily accessible format helping researchers stay abreast of the latest enabling methods and applications in flow cytometry.

Workforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results

Retrieved on: 
Tuesday, May 8, 2018
Medicine, Clinical medicine, Medical tests, Chemistry, Doping in sport, Drug control law, Drug test, Tests, Workplace, Quest Diagnostics, Cocaine

2018 marks thirty consecutive years of the Quest Diagnostics Drug Testing Index (DTI), an analysis of national workplace drug positivity trends based on the company's de-identified laboratory data.

Key Points: 
  • 2018 marks thirty consecutive years of the Quest Diagnostics Drug Testing Index (DTI), an analysis of national workplace drug positivity trends based on the company's de-identified laboratory data.
  • In 1988, the DTI analysis found that the overall drug positivity rate among American workers was 13.6 percent.
  • The positivity rate for cocaine increased for the fifth consecutive year in the general U.S. workforce across every specimen type.
  • 30th Anniversary: In 2018, The Quest Diagnostics Drug Testing Index celebrates 30 years of examining drug test results in the U.S. workforce.

The Companion Diagnostics (CDX) Market Forecast 2018-2028 - Visiongain Report

Retrieved on: 
Thursday, April 19, 2018
Medicine, Clinical medicine, Health, Medical tests, Theranostics, Companion diagnostic, Personalized medicine

Our new report discusses issues and events affecting the companion diagnostics market .

Key Points: 
  • Our new report discusses issues and events affecting the companion diagnostics market .
  • In summary, our 183-page report gives you the following knowledge:
    Revenue forecasts to 2028 for the Companion Diagnostics market- discover the industry's prospects, finding promising places for investments and revenues
    Revenue forecasts to 2028 for each major submarket- discover prospects for leading companion diagnostics products in the following areas: theranostics and other companion diagnostics.
  • Visiongain's study is for everybody needing commercial analyses for the companion diagnostics market and leading companies.
  • To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100

Global Point-of-Care/Rapid Diagnostics Market (2018-2022) Forecast to Grow at a CAGR of 10% - High Prevalence of Infectious Diseases in Developing Countries

Retrieved on: 
Saturday, April 14, 2018
Biotechnology, Medical tests, Biology, Nanotechnology, Molecular diagnostics, Microfluidics, Nature, Technology

The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10% during the forecast period.

Key Points: 
  • The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10% during the forecast period.
  • Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally.
  • The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period.
  • Based on platforms, the point-of-care diagnostics market is further segmented into lateral flow assays, immunoassays, POC molecular diagnostics, dipsticks, and microfluidics.